Literature DB >> 16699000

Separate basic region motifs within the adeno-associated virus capsid proteins are essential for infectivity and assembly.

Joshua C Grieger1, Stephen Snowdy, Richard J Samulski.   

Abstract

Adeno-associated virus (AAV) is gaining momentum as a gene therapy vector for human applications. However, there remain impediments to the development of this virus as a vector. One of these is the incomplete understanding of the biology of the virus, including nuclear targeting of the incoming virion during initial infection, as well as assembly of progeny virions from structural components in the nucleus. Toward this end, we have identified four basic regions (BR) on the AAV2 capsid that represent possible nuclear localization sequence (NLS) motifs. Mutagenesis of BR1 ((120)QAKKRVL(126)) and BR2 ((140)PGKKRPV(146)) had minor effects on viral infectivity ( approximately 4- and approximately 10-fold, respectively), whereas BR3 ((166)PARKRLN(172)) and BR4 ((307)RPKRLN(312)) were found to be essential for infectivity and virion assembly, respectively. Mutagenesis of BR3, which is located in Vp1 and Vp2 capsid proteins, does not interfere with viral production or trafficking of intact AAV capsids to the nuclear periphery but does inhibit transfer of encapsidated DNA into the nucleus. Substitution of the canine parvovirus NLS rescued the BR3 mutant to wild-type (wt) levels, supporting the role of an AAV NLS motif. In addition, rAAV2 containing a mutant form of BR3 in Vp1 and a wt BR3 in Vp2 was found to be infectious, suggesting that the function of BR3 is redundant between Vp1 and Vp2 and that Vp2 may play a role in infectivity. Mutagenesis of BR4 was found to inhibit virion assembly in the nucleus of transfected cells. This affect was not completely due to the inefficient nuclear import of capsid subunits based on Western blot analysis. In fact, aberrant capsid foci were observed in the cytoplasm of transfected cells, compared to the wild type, suggesting a defect in early viral assembly or trafficking. Using three-dimensional structural analysis, the lysine- and arginine-to-asparagine change disrupts hydrogen bonding between these basic residues and adjacent beta strand glutamine residues that may prevent assembly of intact virions. Taken together, these data support that the BR4 domain is essential for virion assembly. Each BR was also found to be conserved in serotypes 1 to 11, suggesting that these regions are significant and function similarly in each serotype. This study establishes the importance of two BR motifs on the AAV2 capsid that are essential for infectivity and virion assembly.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16699000      PMCID: PMC1472161          DOI: 10.1128/JVI.02723-05

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  69 in total

1.  Four casein kinase I isoforms are differentially partitioned between nucleus and cytoplasm.

Authors:  Z Fu; T Chakraborti; S Morse; G S Bennett; G Shaw
Journal:  Exp Cell Res       Date:  2001-10-01       Impact factor: 3.905

2.  Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection.

Authors:  Yuji Kashiwakura; Kenji Tamayose; Kazuhisa Iwabuchi; Yukihiko Hirai; Takashi Shimada; Kunio Matsumoto; Toshikazu Nakamura; Masami Watanabe; Kazuo Oshimi; Hiroyuki Daida
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  Sequence requirements for nuclear location of simian virus 40 large-T antigen.

Authors:  D Kalderon; W D Richardson; A F Markham; A E Smith
Journal:  Nature       Date:  1984 Sep 6-11       Impact factor: 49.962

4.  Infection of purified nuclei by adeno-associated virus 2.

Authors:  J Hansen; K Qing; A Srivastava
Journal:  Mol Ther       Date:  2001-10       Impact factor: 11.454

5.  Localization to the nucleolus is a common feature of coronavirus nucleoproteins, and the protein may disrupt host cell division.

Authors:  T Wurm; H Chen; T Hodgson; P Britton; G Brooks; J A Hiscox
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

6.  A viral phospholipase A2 is required for parvovirus infectivity.

Authors:  Z Zádori; J Szelei; M C Lacoste; Y Li; S Gariépy; P Raymond; M Allaire; I R Nabi; P Tijssen
Journal:  Dev Cell       Date:  2001-08       Impact factor: 12.270

7.  Targeting of E. coli beta-galactosidase to the nucleus in yeast.

Authors:  M N Hall; L Hereford; I Herskowitz
Journal:  Cell       Date:  1984-04       Impact factor: 41.582

8.  Identification of a nuclear localization signal and nuclear export signal of the umbraviral long-distance RNA movement protein.

Authors:  Eugene V Ryabov; Sang Hyon Kim; Michael Taliansky
Journal:  J Gen Virol       Date:  2004-05       Impact factor: 3.891

9.  Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus.

Authors:  Kenneth H Warrington; Oleg S Gorbatyuk; Jeffrey K Harrison; Shaun R Opie; Sergei Zolotukhin; Nicholas Muzyczka
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

10.  Movement of a karyophilic protein through the nuclear pores of oocytes.

Authors:  C M Feldherr; E Kallenbach; N Schultz
Journal:  J Cell Biol       Date:  1984-12       Impact factor: 10.539

View more
  65 in total

1.  Modeling the step of endosomal escape during cell infection by a nonenveloped virus.

Authors:  Thibault Lagache; Olivier Danos; David Holcman
Journal:  Biophys J       Date:  2012-03-06       Impact factor: 4.033

2.  Chemical Modulation of Endocytic Sorting Augments Adeno-associated Viral Transduction.

Authors:  Garrett E Berry; Aravind Asokan
Journal:  J Biol Chem       Date:  2015-11-02       Impact factor: 5.157

Review 3.  Adeno-associated Virus as a Mammalian DNA Vector.

Authors:  Max Salganik; Matthew L Hirsch; Richard Jude Samulski
Journal:  Microbiol Spectr       Date:  2015-08

4.  Proteolytic mapping of the adeno-associated virus capsid.

Authors:  Kim Van Vliet; Veronique Blouin; Mavis Agbandje-McKenna; Richard O Snyder
Journal:  Mol Ther       Date:  2006-09-27       Impact factor: 11.454

5.  Structure of adeno-associated virus serotype 8, a gene therapy vector.

Authors:  Hyun-Joo Nam; Michael Douglas Lane; Eric Padron; Brittney Gurda; Robert McKenna; Erik Kohlbrenner; George Aslanidi; Barry Byrne; Nicholas Muzyczka; Sergei Zolotukhin; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2007-08-29       Impact factor: 5.103

6.  Detection of intact rAAV particles up to 6 years after successful gene transfer in the retina of dogs and primates.

Authors:  Knut Stieger; Josef Schroeder; Nathalie Provost; Alexandra Mendes-Madeira; Brahim Belbellaa; Guylène Le Meur; Michel Weber; Jack-Yves Deschamps; Birgit Lorenz; Philippe Moullier; Fabienne Rolling
Journal:  Mol Ther       Date:  2008-12-23       Impact factor: 11.454

7.  Mapping a neutralizing epitope onto the capsid of adeno-associated virus serotype 8.

Authors:  Brittney L Gurda; Christina Raupp; Ruth Popa-Wagner; Matthias Naumer; Norman H Olson; Robert Ng; Robert McKenna; Timothy S Baker; Jürgen A Kleinschmidt; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

8.  Capsid antibodies to different adeno-associated virus serotypes bind common regions.

Authors:  Brittney L Gurda; Michael A DiMattia; Edward B Miller; Antonette Bennett; Robert McKenna; Wendy S Weichert; Christian D Nelson; Wei-jun Chen; Nicholas Muzyczka; Norman H Olson; Robert S Sinkovits; John A Chiorini; Sergei Zolotutkhin; Olga G Kozyreva; R Jude Samulski; Timothy S Baker; Colin R Parrish; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2013-06-12       Impact factor: 5.103

9.  Adeno-associated virus capsid antigen presentation is dependent on endosomal escape.

Authors:  Chengwen Li; Yi He; Sarah Nicolson; Matt Hirsch; Marc S Weinberg; Ping Zhang; Tal Kafri; R Jude Samulski
Journal:  J Clin Invest       Date:  2013-02-01       Impact factor: 14.808

10.  Structure and dynamics of adeno-associated virus serotype 1 VP1-unique N-terminal domain and its role in capsid trafficking.

Authors:  Balasubramanian Venkatakrishnan; Joseph Yarbrough; John Domsic; Antonette Bennett; Brian Bothner; Olga G Kozyreva; R Jude Samulski; Nicholas Muzyczka; Robert McKenna; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2013-02-20       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.